Karen Auditore-Hargreaves
Amministratore Delegato presso ODC Therapy, Inc.
Profilo
Karen Auditore-Hargreaves is the Chief Executive Officer at ODC Therapy, Inc. since 2005.
Prior to this, she was the President & Chief Operating Officer at Poniard Pharmaceuticals, Inc. from 1999 to 2005.
She also held positions as Vice President-Scientific Affairs at ThermoGenesis Holdings, Inc. and Vice President-Research at CellPro, Inc. Dr. Auditore-Hargreaves holds a doctorate degree from the University of California, Davis.
Posizioni attive di Karen Auditore-Hargreaves
| Società | Posizione | Inizio |
|---|---|---|
ODC Therapy, Inc.
 ODC Therapy, Inc. Medical/Nursing ServicesHealth Services ODC Therapy, Inc. operates offices of physical, occupational and speech therapists and audiologists. The company develops, produces and distributes customized cancer vaccines to individual patients and then monitors their immune response after treatment. The company was founded in 2004 and is headquartered in Dallas, TX. | Amministratore Delegato | 01/06/2005 |
Precedenti posizioni note di Karen Auditore-Hargreaves
| Società | Posizione | Fine |
|---|---|---|
| PONIARD PHARMACEUTICALS, INC. | Presidente | 15/06/2005 |
| THERMOGENESIS HOLDINGS, INC. | Direttore Tecnico/Scientifico/R&S | - |
| CellPro, Inc. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Karen Auditore-Hargreaves
| University of California, Davis | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PONIARD PHARMACEUTICALS, INC. | Health Technology |
| THERMOGENESIS HOLDINGS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
ODC Therapy, Inc.
ODC Therapy, Inc. Medical/Nursing ServicesHealth Services ODC Therapy, Inc. operates offices of physical, occupational and speech therapists and audiologists. The company develops, produces and distributes customized cancer vaccines to individual patients and then monitors their immune response after treatment. The company was founded in 2004 and is headquartered in Dallas, TX. | Health Services |
| CellPro, Inc. | Health Technology |
- Borsa valori
- Insiders
- Karen Auditore-Hargreaves
